Home | Careers | Contact Company Drug Development Technology News & Publications Company Overview Management Scientists Investors Company Overview Artielle Immunotherapeutics is a clinical stage, venture-backed company headquartered in Portland, OR. Artielle is developing a novel class of drugs ...

Home | Careers | Contact Company Drug Development Technology News & Publications Autoimmune Disease Overview Multiple Sclerosis (MS) Celiac Disease Uveitis Rheumatoid Arthritis (RA) Clinical Trials Multiple Sclerosis (MS) Autoimmune Inflammatory Diseases The term "Autoimmune Disease" refers to a...

Home | Careers | Contact Company Drug Development Technology News & Publications Autoimmune Disease Overview Multiple Sclerosis (MS) Celiac Disease Uveitis Rheumatoid Arthritis (RA) Clinical Trials Multiple Sclerosis (MS) Multiple Sclerosis Multiple Sclerosis is caused when T cells, components o...

Home | Careers | Contact Company Drug Development Technology News & Publications Artielle ImmunoTherapeutics Artielle ImmunoTherapeutics' technology is focused on a new proprietary class of molecules known as Recombinant T cell receptor Ligands (RTLs) that can be tailored to treat a wide range o...

Home | Careers | Contact Company Drug Development Technology News & Publications Company Overview Management Scientists Investors Company Overview Artielle Immunotherapeutics is a clinical stage, venture-backed company headquartered in Portland, OR. Artielle is developing a novel class of drugs ...